The FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.

The FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.

FDA grants accelerated approval to Sanofi Tzield for children with newly diagnosed stage 3 type 1 diabetes, backed by Phase 3 data.